Latest Articles
Trastuzumab Pamirtecan Elicits Responses in HER2-Expressing Advanced/Metastatic Endometrial Cancer - OncLive
Trastuzumab Pamirtecan Elicits Responses in HER2-Expressing Advanced/Metastatic Endometrial Cancer OncLive
Published: April 11, 2026, 6:14 p.m.
BioNTech's Trastuzumab Pamirtecan Achieves Positive Phase 2 Results in Advanced HER2-Expressing Endometrial Cancer - Quiver Quantitative
BioNTech's Trastuzumab Pamirtecan Achieves Positive Phase 2 Results in Advanced HER2-Expressing Endometrial Cancer Quiver Quantitative
Published: April 11, 2026, 11:10 a.m.
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer - The Manila Times
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer The Manila Times
Published: April 11, 2026, 11:01 a.m.
In recurrent endometrial cancer, BioNTech drug held off progression 8 months - Stock Titan
In recurrent endometrial cancer, BioNTech drug held off progression 8 months Stock Titan
Published: April 11, 2026, 11 a.m.
Progesterone in MHT for Protection Against Endometrial Cancer - The Vajenda
Progesterone in MHT for Protection Against Endometrial Cancer The Vajenda
Published: April 11, 2026, 9:17 a.m.
THE RIGHT TO REST: WHY SOUTH AFRICAN WOMEN SHOULD GET MENSTRUAL LEAVE - PressReader
THE RIGHT TO REST: WHY SOUTH AFRICAN WOMEN SHOULD GET MENSTRUAL LEAVE PressReader
Published: April 11, 2026, 12:01 a.m.
USWNT boss Emma Hayes opens up on handling pressure and living with endometriosis - MSN
USWNT boss Emma Hayes opens up on handling pressure and living with endometriosis MSN
Published: April 10, 2026, 7:29 p.m.
Menstrual Disorders Reducing Women’s Productivity, Experts Raise Alarm - freedomonline.com.ng
Menstrual Disorders Reducing Women’s Productivity, Experts Raise Alarm freedomonline.com.ng
Published: April 10, 2026, 7:02 p.m.
Prince Harry sued by charity he set up in Africa to honor late mother Princess Diana - 13newsnow.com
Prince Harry sued by charity he set up in Africa to honor late mother Princess Diana 13newsnow.com
Published: April 10, 2026, 6:14 p.m.
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as Highly Expressed, Clinically Relevant Target for Gynecologic Cancers - National Today
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as Highly Expressed, Clinically Relevant Target for Gynecologic Cancers National Today
Published: April 10, 2026, 4:35 p.m.
Link copied to clipboard!